Pharmacokinetic behaviour of a deglycosylated t-PA mutant lacking the growth factor domain.
Mitchell
D L
DL
Department of Biotechnology, SmithKline Beecham Pharmaceuticals, Epsom, Surrey.
Dodd
I
I
Esmail
A F
AF
Browne
M J
MJ
D000818:Animals; D002460:Cell Line; D004591:Electrophoresis, Polyacrylamide Gel; D006133:Growth Substances / Q000235:genetics; D006168:Guinea Pigs; D008657:Metabolic Clearance Rate; D051379:Mice; D011994:Recombinant Proteins / Q000235:genetics / Q000302:isolation & purification / Q000493:pharmacokinetics*; D017384:Sequence Deletion; D010959:Tissue Plasminogen Activator / Q000097:blood / Q000302:isolation & purification / Q000493:pharmacokinetics*; D014162:Transfection
D006133:Growth Substances; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator